158 related articles for article (PubMed ID: 18207381)
41. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective.
Beletsky L; Heller D; Jenness SM; Neaigus A; Gelpi-Acosta C; Hagan H
Int J Drug Policy; 2014 Jan; 25(1):105-11. PubMed ID: 23916801
[TBL] [Abstract][Full Text] [Related]
42. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
43. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
[TBL] [Abstract][Full Text] [Related]
44. The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors.
Perngmark P; Vanichseni S; Celentano DD
Drug Alcohol Depend; 2008 Jan; 92(1-3):183-90. PubMed ID: 17870252
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
Falster K; Kaldor JM; Maher L;
J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
[TBL] [Abstract][Full Text] [Related]
46. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
[TBL] [Abstract][Full Text] [Related]
47. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
[TBL] [Abstract][Full Text] [Related]
48. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
49. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267
[TBL] [Abstract][Full Text] [Related]
50. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
51. Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog.
Otiashvili D; Latypov A; Kirtadze I; Ibragimov U; Zule W
Subst Abuse Treat Prev Policy; 2016 Jun; 11(1):21. PubMed ID: 27251514
[TBL] [Abstract][Full Text] [Related]
52. Injecting drug users: a stigmatised and stigmatising population.
Simmonds L; Coomber R
Int J Drug Policy; 2009 Mar; 20(2):121-30. PubMed ID: 17981451
[TBL] [Abstract][Full Text] [Related]
53. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Ganju D; Ramesh S; Saggurti N
Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
[TBL] [Abstract][Full Text] [Related]
55. Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark.
Kinnard EN; Howe CJ; Kerr T; Skjødt Hass V; Marshall BD
Harm Reduct J; 2014 Oct; 11(1):29. PubMed ID: 25352296
[TBL] [Abstract][Full Text] [Related]
56. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
[TBL] [Abstract][Full Text] [Related]
57. Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands.
Havinga P; van der Velden C; de Gee A; van der Poel A
Harm Reduct J; 2014 Feb; 11():6. PubMed ID: 24524263
[TBL] [Abstract][Full Text] [Related]
58. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.
Todd CS; Abed AM; Strathdee SA; Scott PT; Botros BA; Safi N; Earhart KC
Emerg Infect Dis; 2007 Sep; 13(9):1327-31. PubMed ID: 18252103
[TBL] [Abstract][Full Text] [Related]
59. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
[TBL] [Abstract][Full Text] [Related]
60. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
